This is the first study that illustrates the effective circumvention of doxorubicin resistance by indomethacin-induced activation of the death receptor apoptosis pathway in a doxorubicin-resistant SCLC cell line independent of Fas. This evidence concerns the gene FAS and small cell lung carcinoma.